ID (ISN) del documento | 48831 |
Número CIS |
88-323 |
ISSN - Título de la serie |
0140-6736 - Lancet |
Año |
1987 |
Número de serie |
|
Autor(es) |
Lahaye D., Strauss P., Baleux C., Van Ganse W. |
Título |
Cost-benefit analysis of hepatitis-B vaccination |
Información bibliográfica |
22 Aug. 1987, Vol.2, No.8556, p.441-442. Illus. 4 ref. |
Resumen |
The cost of vaccinating 40,000 Belgian health-care workers against hepatitis-B has been more than recovered by a very serious reduction in the number of compensable cases of the disease. The Belgian Insurance Fund for Occupational Diseases has been paying the costs of hepatitis-B vaccinations since 1983, and this financial investment has proved to be beneficial to the Fund. |
Descriptores (primarios) |
Bélgica; hepatitis vírica; coste de las enfermedades; vacunación; hospitales |
Descriptores (secundarios) |
reparación de las enfermedades profesionales; reparación de los accidentes y enfermedades; papel de los aseguradores |
Tipo de documento |
D - Artículos periódicos |
Tema(s) |
Cemercio, servicios, oficinas
|
Broad subject area(s) |
Riesgos biológicos
|
Navegación por categoria(s) |
Liver diseases Viral diseases (other than aids) Health care services Aspectos económicos Bacterial and parasitic diseases
|